203 related articles for article (PubMed ID: 1371712)
1. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
Ambros RA; Kurman RJ
Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
[TBL] [Abstract][Full Text] [Related]
2. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion.
Ambros RA; Kurman RJ
Gynecol Oncol; 1992 Jun; 45(3):235-9. PubMed ID: 1612497
[TBL] [Abstract][Full Text] [Related]
3. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
[TBL] [Abstract][Full Text] [Related]
4. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma.
Piver MS; Hempling RE
Cancer; 1990 Sep; 66(6):1133-8. PubMed ID: 2400965
[TBL] [Abstract][Full Text] [Related]
5. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy for stage I, grade 2 endometrial adenocarcinoma and adenoacanthoma with limited myometrial invasion.
Fanning J; Evans MC; Peters AJ; Samuel M; Harmon ER; Bates JS
Obstet Gynecol; 1987 Dec; 70(6):920-2. PubMed ID: 3120068
[TBL] [Abstract][Full Text] [Related]
7. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
8. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
Jacques SM; Lawrence WD
Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.
Doering DL; Barnhill DR; Weiser EB; Burke TW; Woodward JE; Park RC
Obstet Gynecol; 1989 Dec; 74(6):930-3. PubMed ID: 2586959
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons.
Eifel PJ; Ross J; Hendrickson M; Cox RS; Kempson R; Martinez A
Cancer; 1983 Sep; 52(6):1026-31. PubMed ID: 6883271
[TBL] [Abstract][Full Text] [Related]
11. Assessment of depth of myometrial invasion in endometrial adenocarcinoma.
Goff BA; Rice LW
Gynecol Oncol; 1990 Jul; 38(1):46-8. PubMed ID: 2354826
[TBL] [Abstract][Full Text] [Related]
12. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of adenomyosis in endometrial carcinoma.
Hall JB; Young RH; Nelson JH
Gynecol Oncol; 1984 Jan; 17(1):32-40. PubMed ID: 6693051
[TBL] [Abstract][Full Text] [Related]
14. Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression.
Nazeer T; Ballouk F; Malfetano JH; Figge H; Ambros RA
Am J Obstet Gynecol; 1995 Dec; 173(6):1829-34. PubMed ID: 8610771
[TBL] [Abstract][Full Text] [Related]
15. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
[TBL] [Abstract][Full Text] [Related]
16. [Treatment and prognosis of pT2 endometrial carcinoma].
Tamura H; Nakai Y; Nagano T; Ohara A; Shibamoto T; Nakayama T; Ohnishi T; Wakutani K; Taniguchi F; Suzuki N
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):315-20. PubMed ID: 2045699
[TBL] [Abstract][Full Text] [Related]
17. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of myometrial invasion in endometrial carcinoma.
Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
[TBL] [Abstract][Full Text] [Related]
19. The role of radiation therapy in the treatment of adenocarcinoma of the corpus uteri stage I. A ten year experience (1970-1979).
Calitchi E; Lobo PA; Martin M; Mazeron JJ; Le Bourgeois JP; Pierquin B
Acta Radiol Oncol; 1984; 23(6):461-4. PubMed ID: 6099040
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma.
Fanning J; Tsukada Y; Piver MS
Gynecol Oncol; 1990 Apr; 37(1):47-50. PubMed ID: 2323612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
